Gene · 1654
Papers3,637
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 3,637
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Dissecting the Interaction Domains of SARS-CoV-2 Nucleocapsid Protein and Human RNA Helicase DDX3X and Search for Potential Inhibitors. | Int J Mol Sci | 2026 | 41596323 | PubTator, text mining | PubMed |
| Effector-host interactome map links type III secretion systems in healthy gut microbiomes to immune modulation. | Nat Microbiol | 2026 | 41588163 | PubTator, text mining | PubMed |
| Correction: A motif unique to the human dead-box protein DDX3 is important for nucleic acid binding, ATP hydrolysis, RNA/DNA unwinding and HIV-1 replication. | PLoS One | 2026 | 41587182 | PubTator, text mining | PubMed |
| Targeting the DDX3/PAF1 axis enhances chemotherapy efficacy in pancreatic ductal adenocarcinoma. | Cancer Lett | 2026 | 41581643 | PubTator, text mining | PubMed |
| Host E3 ligase RNF2 restricts African swine fever virus replication through targeting viral pA104R for its K5 site ubiquitination degradation. | Cell Mol Life Sci | 2026 | 41575554 | PubTator, text mining | PubMed |
| E3 ubiquitin ligase trim36 targets ddx3x for degradation to reprogram macrophage polarization and ameliorate tubal factor infertility in rats. | Cell Biol Toxicol | 2026 | 41553545 | PubTator, text mining | PubMed |
| Epigenomic, transcriptomic, and proteomic characterization of breast cancer cell line reference samples. | Cell Rep Methods | 2026 | 41539304 | PubTator, text mining | PubMed |
| Epstein-Barr Virus-Associated T/NK-Cell Neoplasms. | J Med Virol | 2026 | 41510998 | PubTator, text mining | PubMed |
| Integrative analysis of single-cell and bulk RNA sequencing data for discovery of senescent TAMs prognostic characteristics in neuroblastoma. | BMC Cancer | 2026 | 41491450 | PubTator, text mining | PubMed |
| Circular RNA SETD2 (circSETD2) elevates DDX3 expression to inhibit autophagy in hepatitis B virus infection via targeting miR-181a-5p. | BMC Infect Dis | 2026 | 41484997 | PubTator, text mining | PubMed |
| Mutational Spectrum of T-Cell Large Granular Lymphocytic Leukemia: Insights From the AACR Project GENIE Consortium. | Cancer Genomics Proteomics | 2026 | 41482347 | PubTator, text mining | PubMed |
| Enhanced Identifications and Quantification Through Retention Time Down-Sampling in Fast-Cycling Diagonal-PASEF Methods. | Mol Cell Proteomics | 2026 | 41380996 | PubTator, text mining | PubMed |
| OTUD4-ZMYND8-DDX3X Axis Drives Immunosuppressive Microenvironment in Spinal Metastases of Triple-Negative Breast Cancer. | Neoplasia | 2026 | 41297414 | PubTator, text mining | PubMed |
| Leaf it to science: Uncovering plant immune systems through technological advances. | Plant Physiol | 2026 | 41289031 | PubTator, text mining | PubMed |
| Fluorescent protein and peptide tags alter condensate formation and dynamics in vivo and in vitro. | EMBO Rep | 2026 | 41266615 | PubTator, text mining | PubMed |
| DDX3X induces mesenchymal transition of endothelial cells by disrupting BMPR2 signaling. | FEBS Open Bio | 2026 | 41186241 | PubTator, text mining | PubMed |
| Clinico-hematopathologic and Genetic Characteristics of Korean Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm: A Retrospective Single-Center Cohort Study. | Ann Lab Med | 2026 | 41093602 | PubTator, text mining | PubMed |
| The LMSz method - an automatable scalable approach to constructing gene-specific growth charts in rare disorders. | Eur J Hum Genet | 2026 | 41077617 | PubTator, text mining | PubMed |
| The Great Escape: A Case Series on DDX3X Craniofacial Phenotypes in Females. | Cleft Palate Craniofac J | 2026 | 41042938 | PubTator, text mining | PubMed |
| A novel lncRNA, lncMCL1, modulates neural pyroptosis associated with epilepsy via stabilizing DDX3X. | Cell Death Differ | 2026 | 40983632 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1654/papers?page=5